Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Schena

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy. Methods & Clinical Development|December 1, 2025
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2Chiara Rigamonti, Dimitri Bulté, Federica Barzaghi, et al.
Annals of the Rheumatic Diseases|May 20, 2017
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national studyRoberta Caorsi, Federica Penco, Alice Grossi, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2024
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severitiesDimitri Bulté, Federica Barzaghi, Cristina Mesa-Nuñez, et al.
The Journal of Allergy and Clinical Immunology|May 31, 2015
Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseasesDirk Holzinger, Selina Kathleen Fassl, Wilco de Jager, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy. Methods & Clinical Development|December 1, 2025
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2Chiara Rigamonti, Dimitri Bulté, Federica Barzaghi, et al.
Annals of the Rheumatic Diseases|May 20, 2017
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national studyRoberta Caorsi, Federica Penco, Alice Grossi, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2024
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severitiesDimitri Bulté, Federica Barzaghi, Cristina Mesa-Nuñez, et al.
The Journal of Allergy and Clinical Immunology|May 31, 2015
Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseasesDirk Holzinger, Selina Kathleen Fassl, Wilco de Jager, et al.
Pageof 4